The two major modalities of pharmacomechanical coupling, inositol 1,4,5 trisphosphate induced Ca2+ release and modulation of Ca2+-sensitivity, are reviewed. Recent studies show that although changes in cytoplasmic Ca2+ play the major role in regulating smooth muscle contraction, agonists can also significantly affect the contractile state by modifying Ca2+- sensitivity. Inhibition of myosin light chain kinase or myosin light chain phosphatase leads to, respectively, desensitization or sensitization of the contractile apparatus to Ca2+, G-protein linked inhibition of myosin light chain phosphatase and Ca2+ release mediated by the phosphatidylinol cascade are the two major pharmacomechanical coupling mechanisms.
CITATION STYLE
Somlyo, A. V., Somlyo, A. P., Prinzen, F., Allen, D., Holloway, C., & Kass, D. (1993). Intracellular signaling in vascular smooth muscle. In Advances in Experimental Medicine and Biology (Vol. 346, pp. 31–38). Springer New York LLC. https://doi.org/10.1007/978-1-4615-2946-0_4
Mendeley helps you to discover research relevant for your work.